Director Ali Behbahani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director ali behbahani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Ali Behbahani Today - Breaking & Trending Today

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.6% in September

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 1,420,000 shares, an increase of 24.6% from the August 31st total of 1,140,000 shares. Currently, 4.1% of the company’s stock are short sold. Based on […] ....

Black Diamond , Ali Behbahani , Stifel Nicolaus , Piper Sandler , Herbst Group , Charles Schwab Investment Management Inc , Capital Management , Diamond Therapeutics Company Profile , Securities Exchange Commission , Cubist Systematic Strategies , Diamond Therapeutics Inc , Black Diamond Therapeutics , Get Free Report , Director Ali Behbahani , Exchange Commission , Schwab Investment Management , Montreal Can , Systematic Strategies , Diamond Therapeutics Stock Down , Diamond Therapeutics , Black Diamond Therapeutics Daily , Nasdaq Bdtx ,

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Down 67.3% in July

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,040,000 shares, a decline of 67.3% from the July 15th total of 3,180,000 shares. Based on an average trading volume of 4,090,000 shares, the days-to-cover […] ....

Black Diamond , Davidm Epstein , Stifel Nicolaus , Piper Sandler , Ali Behbahani , Diamond Therapeutics Inc , Charles Schwab Investment Management Inc , Capital Management , Herbst Group , Cubist Systematic Strategies , Securities Exchange Commission , Black Diamond Therapeutics , Get Free Report , Director Ali Behbahani , Exchange Commission , Systematic Strategies , Schwab Investment Management , Montreal Can , Diamond Therapeutics , Black Diamond Therapeutics Daily , Nasdaq Bdtx ,

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Drop in Short Interest

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Drop in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Black Diamond , Stifel Nicolaus , Davidm Epstein , Piper Sandler , Ali Behbahani , Cubist Systematic Strategies , Charles Schwab Investment Management Inc , Capital Management , Securities Exchange Commission , Herbst Group , Diamond Therapeutics Inc , Black Diamond Therapeutics , Get Free Report , Director Ali Behbahani , Exchange Commission , Systematic Strategies , Schwab Investment Management , Montreal Can , Diamond Therapeutics Stock Down , Diamond Therapeutics , Black Diamond Therapeutics Daily ,

Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $11.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Wedbush upgraded shares of Black […] ....

Davidm Epstein , Ali Behbahani , Stifel Nicolaus , Piper Sandler , Marquette Asset Management , Diamond Therapeutics Inc , Herbst Group , Capital Management , Securities Exchange Commission , Dimensional Fund Advisors , Cubist Systematic Strategies , Diamond Therapeutics Company Profile , Black Diamond Therapeutics , Free Report , Marketbeat Ratings , Diamond Therapeutics , Get Free Report , Black Diamond , Director Ali Behbahani , Exchange Commission , Systematic Strategies , Asset Management , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Initiated Coverage ,

Black Diamond Therapeutics (NASDAQ:BDTX) Now Covered by Piper Sandler

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 target price on the stock. Several other equities analysts also recently issued reports on BDTX. Stifel Nicolaus raised shares of Black Diamond Therapeutics from […] ....

Piper Sandler , Stifel Nicolaus , Ali Behbahani , Healthcare Of Ontario Pension Plan Trust Fund , Millennium Management , Diamond Therapeutics Inc , Renaissance Technologies , Jpmorgan Chase Co , Goldman Sachs Group Inc , Black Diamond Therapeutics , Free Report , Diamond Therapeutics , Get Free Report , Director Ali Behbahani , Ontario Pension Plan Trust Fund , Goldman Sachs Group , Sachs Group , Black Diamond Therapeutics Daily , Nasdaq Bdtx , Initiated Coverage ,